These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure. Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020. Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645 [TBL] [Abstract][Full Text] [Related]
9. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing. Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection and Mitigation Efforts among Office Workers, Washington, DC, USA. Sami S; Vuong N; Miller H; Priestley R; Payne M; Licata-Portentoso G; Drobeniuc J; Petersen LR Emerg Infect Dis; 2021 Feb; 27(2):669-672. PubMed ID: 33496649 [TBL] [Abstract][Full Text] [Related]
17. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients. Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148 [No Abstract] [Full Text] [Related]
18. SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention Measures. Lizewski RA; Sealfon RSG; Park SW; Smith GR; Porter CK; Gonzalez-Reiche AS; Ge Y; Miller CM; Goforth CW; Pincas H; Termini MS; Ramos I; Nair VD; Lizewski SE; Alshammary H; Cer RZ; Chen HW; George MC; Arnold CE; Glang LA; Long KA; Malagon F; Marayag JJ; Nunez E; Rice GK; Santa Ana E; Schilling MA; Smith DR; Sugiharto VA; Sun P; van de Guchte A; Khan Z; Dutta J; Vangeti S; Voegtly LJ; Weir DL; Metcalf CJE; Troyanskaya OG; Bishop-Lilly KA; Grenfell BT; van Bakel H; Letizia AG; Sealfon SC Epidemiology; 2022 Nov; 33(6):797-807. PubMed ID: 35944149 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis. Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020. Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]